53.7 F
San Diego
Thursday, Mar 28, 2024
-Advertisement-

Promosome Receives First Royalty Payment From GE

Promosome, a privately held synthetic biology company in San Diego, announced Monday that it has received the first royalty payment from its licensing agreement with GE Healthcare Life Sciences.

Promosome also received payments in recognition of the completion of key milestones in the transfer of enabling technologies to GE Healthcare Life Sciences.

In 2014, the companies announced that they would work together to apply Promosome’s suite of mRNA translation-based development tools to enhance the mammalian cell line development services offered by GE Healthcare Life Sciences. Under the terms of agreement, Promosome will receive milestone payments for the technology transfer and royalties on sales of Promosome-enabled services.

Financial details were not disclosed.

-Advertisement-

Featured Articles

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-